Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-10-03

Clinical Trial Update: Efficacy Vulvovaginitis Candida [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing efficacy for vulvovaginal candidiasis sponsored by J. Uriach and Company was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: J. Uriach and Company | Conditions: Candidiasis Vulvaginitis | Phase 2 | Status: TERMINATED